Synthetic bone substitute Tactoset®

for orthopedic surgeryputty

Tactoset® provides a minimally invasive treatment option for bone marrow lesions or insufficiency fractures via percutaneous skeletal fixation.1 The product is used to improve the structural quality of the affected subchondral bone and promote local bone remodeling while preventing subchondral bone collapse and subsequent progression of osteoarthritis. Tactoset is a synthetic, biocompatible, hyaluronic acid-enhanced, calcium phosphate bone graft substitute material intended for filling bone voids or defects of the skeletal system that are not intrinsic to the stability of bony structure. The device provides an injectable, self-setting, osteoconductive bone graft substitute that hardens post-deployment to reinforce weaknesses and mimic the properties of trabecular bone. Tactoset supports cell-mediated regeneration of new bone as it is resorbed and replaced by the growth of new bone during the healing process.